Brief: Inspira Says Co Nears First FDA 510(k) Approval
Feb 27 (Reuters) - Inspira Technologies Oxy BHN Ltd
IINN.O :
* INSPIRA™ ANNOUNCES BREAKTHROUGH UPDATE: NEARS FIRST FDA
510(K)
APPROVAL, 3 U.S. PATENTS APPROVED, $546 MILLION IN SUMMARY
DISTRIBUTION AGREEMENTS
* INSPIRA TECHNOLOGIES OXY BHN LTD: PLANS ADDITIONAL FDA
510(K)
SUBMISSIONS FOR HYLA BLOOD SENSOR IN 2024 AND FOR INSPIRA ART
DISPOSABLES IN 2025
Source text for Eikon: ID:nPnZmMpra
Further company coverage: IINN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qtrex Quantum
See all newsBrief: Qtrex Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Requirement
Brief: Qtrex Quantum Ltd In Discussions With A US Department Of Defense’S Research Laboratory To Establish A Joint Quantum Development Program
Brief: Qtrex Quantum - Offers Up To 6.8 Million Ordinary Shares For Resale By Selling Shareholder - SEC Filing
Brief: Qtrex Expands Into Quantum Processor Interface With Single-Build Cryogenic Chip Carrier
NASDAQ RESUMED AT 11:03 AM